150 related articles for article (PubMed ID: 35565448)
1. Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry.
Sánchez-Sendra B; Pérez-Debén S; González-Muñoz JF; Murgui A; Monteagudo C
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565448
[TBL] [Abstract][Full Text] [Related]
2. Association of the m
Li Y; Cao J; Wang J; Wu W; Jiang L; Sun X
Cancer; 2024 Feb; 130(3):356-374. PubMed ID: 37861451
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
J Clin Pathol; 2014 Jun; 67(6):520-8. PubMed ID: 24607493
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
[TBL] [Abstract][Full Text] [Related]
6. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of
Mancarella C; Pasello M; Manara MC; Toracchio L; Sciandra EF; Picci P; Scotlandi K
Front Endocrinol (Lausanne); 2018; 9():178. PubMed ID: 29731738
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.
Shantha Kumara H; Kirchoff D; Caballero OL; Su T; Ahmed A; Herath SA; Njoh L; Cekic V; Simpson AJ; Cordon-Cardo C; Whelan RL
Oncoscience; 2015; 2(6):607-14. PubMed ID: 26244168
[TBL] [Abstract][Full Text] [Related]
8. IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia.
Zhang J; Ji Q; Jiao C; Ren L; Zhao Y; Chen Y; Shi R; Feng Y
Onco Targets Ther; 2017; 10():3861-3866. PubMed ID: 28814885
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival.
Schaeffer DF; Owen DR; Lim HJ; Buczkowski AK; Chung SW; Scudamore CH; Huntsman DG; Ng SS; Owen DA
BMC Cancer; 2010 Feb; 10():59. PubMed ID: 20178612
[TBL] [Abstract][Full Text] [Related]
10. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study.
Kupczyk P; Simiczyjew A; Marczuk J; Dratkiewicz E; Beberok A; Rok J; Pieniazek M; Biecek P; Nevozhay D; Slowikowski B; Chodaczek G; Wrzesniok D; Nowak D; Donizy P
Cells; 2021 Jan; 10(2):. PubMed ID: 33572647
[TBL] [Abstract][Full Text] [Related]
11. Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
Wirtz RM; Sihto H; Isola J; Heikkilä P; Kellokumpu-Lehtinen PL; Auvinen P; Turpeenniemi-Hujanen T; Jyrkkiö S; Lakis S; Schlombs K; Laible M; Weber S; Eidt S; Sahin U; Joensuu H
Breast Cancer Res Treat; 2016 Jun; 157(3):437-46. PubMed ID: 27220750
[TBL] [Abstract][Full Text] [Related]
12. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
[TBL] [Abstract][Full Text] [Related]
13. Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas.
Sun C; Zheng X; Sun Y; Yu J; Sheng M; Yan S; Zhu Q; Lan Q
Front Genet; 2021; 12():743738. PubMed ID: 34721530
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of
Guo W; Huai Q; Wan H; Guo L; Song P; Gao S; He J
DNA Cell Biol; 2021 Feb; 40(2):316-331. PubMed ID: 33493403
[TBL] [Abstract][Full Text] [Related]
15. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
16. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
18. TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.
Journe F; Id Boufker H; Van Kempen L; Galibert MD; Wiedig M; Salès F; Theunis A; Nonclercq D; Frau A; Laurent G; Awada A; Ghanem G
Br J Cancer; 2011 Nov; 105(11):1726-32. PubMed ID: 22045183
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
20. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]